ES2083103T3 - Procedimiento de una etapa para la produccion de diritromicina. - Google Patents

Procedimiento de una etapa para la produccion de diritromicina.

Info

Publication number
ES2083103T3
ES2083103T3 ES92308839T ES92308839T ES2083103T3 ES 2083103 T3 ES2083103 T3 ES 2083103T3 ES 92308839 T ES92308839 T ES 92308839T ES 92308839 T ES92308839 T ES 92308839T ES 2083103 T3 ES2083103 T3 ES 2083103T3
Authority
ES
Spain
Prior art keywords
diritromicina
procedure
stage
production
erythrocimiline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92308839T
Other languages
English (en)
Inventor
John Mcneil Mcgill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2083103T3 publication Critical patent/ES2083103T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A UN NUEVO PROCESO PARA LA SINTESIS DE LA DIRITROMICINA ANTIBIOTICA EN FORMA CRISTALINA. EL PROCESO SE LLEVA A CABO MEDIANTE UN VASO DE REACCION SIMPLE MEDIANTE EL QUE UN ACETAL DISUELTO EN ACETONITRILO, EN PRESENCIA DE UN CATALIZADOR ACIDO, SE HIDROLIZA CON EL HEMIACETAL RELACIONADO QUE RELACIONA ENTONCES DIRECTAMENTE CON EL ERITROCIMILAMINO PARA FORMAR DIRITROMICINA CRISTALINA.
ES92308839T 1991-09-30 1992-09-28 Procedimiento de una etapa para la produccion de diritromicina. Expired - Lifetime ES2083103T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76880391A 1991-09-30 1991-09-30

Publications (1)

Publication Number Publication Date
ES2083103T3 true ES2083103T3 (es) 1996-04-01

Family

ID=25083529

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92308839T Expired - Lifetime ES2083103T3 (es) 1991-09-30 1992-09-28 Procedimiento de una etapa para la produccion de diritromicina.

Country Status (28)

Country Link
US (1) US5578713A (es)
EP (1) EP0535900B1 (es)
JP (1) JP3197957B2 (es)
KR (1) KR100236246B1 (es)
CN (1) CN1030455C (es)
AR (1) AR248282A1 (es)
AT (1) ATE133178T1 (es)
BR (1) BR9203799A (es)
CA (1) CA2079430A1 (es)
CZ (1) CZ281664B6 (es)
DE (1) DE69207696T2 (es)
DK (1) DK0535900T3 (es)
ES (1) ES2083103T3 (es)
FI (1) FI104969B (es)
GR (1) GR3018726T3 (es)
HK (1) HK1006842A1 (es)
HU (1) HU213620B (es)
IL (1) IL103276A (es)
MX (1) MX9205455A (es)
MY (1) MY113261A (es)
NO (1) NO178150C (es)
NZ (1) NZ244495A (es)
PH (1) PH30959A (es)
RU (1) RU2045534C1 (es)
SK (1) SK279270B6 (es)
TW (1) TW287165B (es)
YU (1) YU48748B (es)
ZA (1) ZA927328B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA966601B (en) * 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
EP1648415A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
EP1658034A4 (en) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
US8715727B2 (en) 2004-07-02 2014-05-06 Shionogi Inc. Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
US4438109A (en) * 1980-07-25 1984-03-20 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Tylosin derivatives
JPS62103098A (ja) * 1985-05-13 1987-05-13 Microbial Chem Res Found タイロシン誘導体

Also Published As

Publication number Publication date
IL103276A (en) 1997-06-10
CZ293592A3 (en) 1993-04-14
AR248282A1 (es) 1995-07-12
ZA927328B (en) 1994-03-24
EP0535900A1 (en) 1993-04-07
NZ244495A (en) 1995-04-27
CA2079430A1 (en) 1993-03-31
CN1070914A (zh) 1993-04-14
TW287165B (es) 1996-10-01
YU48748B (sh) 1999-09-27
AU2536592A (en) 1993-04-01
AU645443B2 (en) 1994-01-13
EP0535900B1 (en) 1996-01-17
CZ281664B6 (cs) 1996-12-11
HU213620B (en) 1997-08-28
DE69207696D1 (de) 1996-02-29
BR9203799A (pt) 1993-04-20
HU9203101D0 (en) 1992-12-28
PH30959A (en) 1997-12-23
SK293592A3 (en) 1998-08-05
US5578713A (en) 1996-11-26
MX9205455A (es) 1993-05-01
NO178150C (no) 1996-01-31
SK279270B6 (sk) 1998-08-05
HUT62308A (en) 1993-04-28
FI924360L (fi) 1993-03-31
KR100236246B1 (ko) 1999-12-15
GR3018726T3 (en) 1996-04-30
KR930006044A (ko) 1993-04-20
NO178150B (no) 1995-10-23
DE69207696T2 (de) 1996-06-05
NO923765L (no) 1993-03-31
CN1030455C (zh) 1995-12-06
YU87792A (sh) 1995-03-27
RU2045534C1 (ru) 1995-10-10
ATE133178T1 (de) 1996-02-15
FI104969B (fi) 2000-05-15
DK0535900T3 (da) 1996-02-12
HK1006842A1 (en) 1999-03-19
JPH05213983A (ja) 1993-08-24
IL103276A0 (en) 1993-02-21
JP3197957B2 (ja) 2001-08-13
NO923765D0 (no) 1992-09-28
MY113261A (en) 2002-01-31
FI924360A0 (fi) 1992-09-29

Similar Documents

Publication Publication Date Title
AR248282A1 (es) Un procedimiento para la preparacion dediritromicina cristalina.
MX9303294A (es) Proceso para la produccion de acido acetico.
ES8206531A1 (es) Metodo para producir un 1,1-dioxopenicilanoiloximetil 6- (d-a-amino-a-fenilacetamido)penicilanato tosilato hidrato cristalino
IT1272109B (it) Processo per la preparazione di apg
ES2120973T3 (es) Sal de diastereomero de acido quinolinmevalonico opticamente activo.
ES2147798T3 (es) Un procedimiento para la produccion de compuestos de tetrazolilo.
ES2104288T3 (es) Procedimiento para la produccion de esteres del acido metacrilico.
MY117968A (en) Process for the production of an aqueous monoester peroxycarboxylic acid solution, the solution obtainable by this process, and its use as disinfectant
ES2074821T3 (es) Sintesis de eter alquil terc.-alquilico usando catalizadores de zeolita.
ES2115678T3 (es) Proceso para producir ester halometilico de acido carboxilico alifatico.
ES8305770A1 (es) Un procedimiento para la preparacion de bis-esteres de metanodiol.
ES2105217T3 (es) Preparacion de intermedios en la sintesis de antibioticos de quinolina.
MX9307292A (es) Sintesis regioselectiva de acido 4-cloro-2-tiofenocarboxilico.
BR0214781A (pt) Processo para a preparação de metionina
ES2055238T3 (es) Procedimiento para producir esteres de acido alfa-ceto-carboxilico.
ES2195364T3 (es) Procedimiento de eterificacion de un alcohol de tipo bencilico, productos obtenidos y sus aplicaciones.
ES2058622T3 (es) Esteres substituidos del acido acrilico.
FI862557A0 (fi) Foerfarande foer framstaellning av en dibromnitrofoerening.
EP0147472A4 (en) 4-chloro-4-methyl-5-methylene-1,3-dioxolan-2-one.
AR245728A1 (es) Un procedimiento para la produccion del antibiotico uk 61689 o una sal farmaceuticamente aceptable del mismo.
ES2181899T3 (es) Procedimiento para la produccion de acido azetidin-2-carboxilico enantiomericamente puro.
MX9304140A (es) Sal de purina, proceso para su preparacion y proceso para preparar un agente antiviral mediante la reaccion de dicha sal.
ES2089654T3 (es) Procedimiento para purificar amidas de acidos grasos.
ES554671A0 (es) Procedimiento para la fabricacion de acidos 6-alcoxi (inferior)-5-halo-1-naftoicos y sus esteres correspondientes
IT7827076A0 (it) Processo per la produzione di acido 2-ammino-2-fenilacetico eventualmente sostituito, otticamente attivo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 535900

Country of ref document: ES